Breaking News on Supplements & Nutrition - North AmericaEU edition
An unbending look at joint health
Aging populations are experiencing a range of health conditions, with deteriorating joints high on the list. In this special series NutraIngredients-USA looks at the science, supply and regulations of the joint health market.
Joint health claims possible in healthy populations: Scientist
Establishing joint health benefits of natural products can be done without using diseased populations, says UCLA’s Dr Jay Udani.
Regulation: Joint sales not hurt by health claim hole
The joint health space is in good shape in most markets globally with (mostly supplement) sales sitting at about $2bn.
Science: The emerging ingredients for joint health
In the fourth part of our series on joint health, we look beyond glucosamine and chondroitin to the next generation of joint health ingredients.
Science: The benefits of glucosamine and omega-3
In the third part of our series on joint health, we look at the sometimes conflicting but always burgeoning science behind the ingredients.
Supply: Joining the glucosamine supply gaps
In the second part of this NutraIngredients focus on joint health, we analyse the elbow work going on in the supply channel.
Glucosamine market reaching maturity
In the first part of a special edition on joint health, Nutraingredients.com looks at the market for the ingredient that far outpaces the others in the pack - glucosamine.
Spotlight
  Vitamin Shoppe: US supplement user confidence soars to 93% as usage increasesTaking dietary supplements can boost confidence about health, according to The Vitamin Shoppe's annual survey, with usage... |
 NBTY: ‘DMAA-containing products represent less than 0.5% of our sales’The FDA crackdown on stimulant DMAA will not have a big impact on supplements giant NBTY, said... |
 Dispatches from AHPA's Botanical CongressFDA: We’re not enforcing NDI draft guidance; GMPs are the biggest issueThe Food & Drug Administration is not preparing to enforce its controversial draft guidance on new dietary... |
 Vitamin Shoppe boss quizzed on DMAA on Q1 earnings callVitamin Shoppe boss Tony Truesdale would not say how much the FDA crackdown on DMAA is likely... |